TAVI innovations: latest breakthroughs from PCR London Valves 2024

Session comprising selected PCR London Valves 2024 Late-Breaking Trials submissions

Discussants: C. R. Agatiello, T. Cahill, C. J. Terkelsen, J. Wang

Facilitators: A. Baumbach, H. Möllmann

Summary

Curious about the latest advancements shaping the future of TAVI? Don't miss this video which deliver insights from the PCR London Valves 2024 Late-Breaking Trials, diving into key topics that matter most in clinical practice.

Explore 5-year outcomes of AVR in low-risk patients stratified by annulus size, compare valve performance between SAPIEN3 Ultra RESILIA and Evolut FX in small aortic annuli, learn about ShortCut, the first FDA-cleared dedicated leaflet-splitting device, and much more!

Presentations available when logged in:

Five-year outcomes after AVR in low-risk patients stratified by annulus size

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

TAVI innovations: latest breakthroughs from PCR London Valves 2024

Session comprising selected PCR London Valves 2024 Late-Breaking Trials submissions

Log in or create account for free